[{"indications": "Indications\u00a0short-term use in anxiety, but see notes above", "name": "MEPROBAMATE ", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.1 Hypnotics and anxiolytics", "4.1.2 Anxiolytics", "Meprobamate", "MEPROBAMATE"], "cautions": "Cautions\u00a0respiratory disease, muscle weakness, epilepsy (may induce seizures), history of drug or alcohol abuse, marked personality disorder; elderly and debilitated; avoid prolonged\r\nuse, abrupt withdrawal (may precipitate\r\nconvulsions); interactions: Appendix\r\n1 (anxiolytics and hypnotics) Driving\u00a0Drowsiness may affect performance\r\nof skilled tasks (e.g. driving); effects\r\nof alcohol enhanced ", "side-effects": "Side-effects\u00a0see under Diazepam, but incidence greater and\r\ndrowsiness most common side-effect; also gastro-intestinal disturbances,\r\nhypotension, paraesthesia, weakness, CNS effects including headache,\r\nparadoxical excitement, disturbances of vision; rarely agranulocytosis\r\nand rashes", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3198.htm", "doses": ["400\u00a0mg 3\u20134 times daily; elderly half adult dose or less; child not\r\nrecommended", "Meprobamate treatment should not be initiated in new patients, see notes above"], "pregnancy": "Pregnancy\u00a0avoid if possible"}]